DFPG Investments’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

DFPG Investments’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$7.98K	Hold	1,081	–	–	﹤0.01%	619
2023 Q3	$10.9K	Hold	1,081	–	–	﹤0.01%	574
2023 Q2	$26.9K	Hold	1,081	–	–	﹤0.01%	573
2023 Q1	$29.1K	Hold	1,081	–	–	﹤0.01%	513
2022 Q4	$42.8K	Hold	1,081	–	–	0.01%	430
2022 Q3	$165K	Hold	1,081	–	–	0.07%	168
2022 Q2	$264K	Hold	1,081	–	–	0.12%	124
2022 Q1	$212K	Hold	1,081	–	–	0.08%	155
2021 Q4	$135K	Hold	1,081	–	–	0.06%	169
2021 Q3	$219K	Hold	1,081	–	–	0.08%	163
2021 Q2	$269K	Hold	1,081	–	–	0.1%	136
2021 Q1	$290K	Hold	1,081	–	–	0.12%	125
2020 Q4	$379K	Buy	+1,081	New	+$310K	0.17%	109

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DFPG Investments's EIGR Position: Q4 2023 in Review

DFPG Investments held its Eiger BioPharmaceuticals, Inc. (EIGR) position steady in Q4 2023 at 1,081 shares worth $7.98K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

DFPG Investments first reported a position in EIGR in Q4 2020 and has held it in 13 quarters since. The position peaked at $379K in Q4 2020. 43 funds tracked by Wall St. Rank hold EIGR as of Q4 2023.

DFPG Investments held 1,081 shares of Eiger BioPharmaceuticals, Inc. worth $7.98K as of Q4 2023.
DFPG Investments left its Eiger BioPharmaceuticals, Inc. share count unchanged in Q4 2023.
Eiger BioPharmaceuticals, Inc. made up ﹤0.01% of DFPG Investments's portfolio in Q4 2023, its #619 holding.
DFPG Investments first reported a position in Eiger BioPharmaceuticals, Inc. in Q4 2020 and has held it in 13 quarters since.
DFPG Investments's Eiger BioPharmaceuticals, Inc. position peaked at $379K in Q4 2020.
43 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2023.

Based on DFPG Investments's 13F filing for Q4 2023, filed 10 Jan 2024.